Press and media
Press releases
More regular updates and key information, updates and news can be found thorugh our tweets
CellCentric successfully completes InnovateUK programme
CellCentric CEO appointed to BBSRC Council
CellCentric featured in Nature Biotechnology
CellCentric publishes on non-oncology indications
Latest tweets from @CellCentric
New oral cancer drug inobrodib is making a difference. Made possible by the combined efforts of patients, physicians, scientists & hospital staff. Thank you. #WorldCancerDay
Many thanks @Labiotech_eu for featuring @CellCentric’s CEO, Will West. Special article on improving cancer care, ahead of #WorldCancerDay2023 https://www.labiotech.eu/in-depth/how-can-cancer-care-be-improved/
Delighted to now have Dave as part of the wider CellCentric team, supporting inobrodib product supply, as we prepare for scale up, pivotal studies.
New oral cancer drug inobrodib is making a difference. Made possible by the combined efforts of patients, physicians, scientists & hospital staff. Thank you. #WorldCancerDay
Many thanks @Labiotech_eu for featuring @CellCentric’s CEO, Will West. Special article on improving cancer care, ahead of #WorldCancerDay2023 https://www.labiotech.eu/in-depth/how-can-cancer-care-be-improved/
Delighted to now have Dave as part of the wider CellCentric team, supporting inobrodib product supply, as we prepare for scale up, pivotal studies.
New oral cancer drug inobrodib is making a difference. Made possible by the combined efforts of patients, physicians, scientists & hospital staff. Thank you. #WorldCancerDay
Many thanks @Labiotech_eu for featuring @CellCentric’s CEO, Will West. Special article on improving cancer care, ahead of #WorldCancerDay2023 https://www.labiotech.eu/in-depth/how-can-cancer-care-be-improved/
Delighted to now have Dave as part of the wider CellCentric team, supporting inobrodib product supply, as we prepare for scale up, pivotal studies.